Fingerprint
Dive into the research topics of 'Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
International Immuno-Oncology Biomarker Working Group
- The Netherlands Cancer Institute
- Ghent University Hospital
- NYU School of Medicine
- Weill Cornell Medical College in Qatar
- European Institute of Oncology (Istituto Europeo di Oncologia)
- Policlinico of Milan
- Vancouver General Hospital, The Prostate Centre, University of British Columbia, Faculty of Medicine
- Indiana University Bloomington
- Gustave Roussy Institute
- Centre de Recherche en Épidemiologie et Sante des Populations (CESP)
- University of Texas M. D. Anderson Cancer Center
- Jules Bordet Institute
- Yale University
- National Cancer Institute, NIH
- Institute for Radiology, CCM
- Philipps-Universitat
- German Breast Group
- University of Melbourne
- Ontario Institute for Cancer Research
- IGMM
- Wales West General Hospital
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT)
- Harvard Medical School
- Institute of Cancer Research
- Breast Cancer Now Toby Robins Research Centre
- Institute of Cancer Research
- Vivactiv Ltd
- University of Ottawa
- KU Leuven
- GZA-ZNA Ziekenhuizen
- Oulu University Hospital
- Matsuyama Shimin Hospital
- Baylor College of Medicine
- Roche Diagnostics
- PhenoPath Laboratories
- Genentech Inc
- University of Turin
- Case Western Reserve University
- Oklahoma City Veterans Affairs Medical Center
- New York University
- Johns Hopkins Hospital
- PathAI
- University of Iowa
- IVO
- GSTT Guy's and St Thomas' NHS Foundation Trust
- King's College London
- Lund University
- UCL University College London
Research output: Contribution to journal › Review article › peer-review
15
Citations
(Scopus)